Larimar Therapeutics News

LifeSci Capital Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $36

Moomoo NewsJul 16 18:31 ET · Ratings

Buy Rating for Larimar Therapeutics Backed by Promising Gene Therapy Advances for Friedreich's Ataxia

TipRanksJul 16 17:35 ET

Friedreich's Ataxia Market to Grow at a Substantial Growth Rate by 2034, Examines DelveInsight | Key Companies - Retrotope, PTC Therapeutics, Minoryx Therapeutics, Biogen, Lexeo Therapeutics, Larimar Therapeutics

GlobeNewswireJul 16 13:00 ET

Lexeo Stock Drops 24% Amid Friedreich Ataxia Study Results

Seeking AlphaJul 15 12:03 ET

Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

BenzingaJul 9 12:59 ET

Nvidia, Micron Leading Chip Stocks Higher Tuesday

BenzingaJul 9 10:05 ET

Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

BenzingaJun 26 07:36 ET

AMC Networks, Louisiana-Pacific And Other Big Stocks Moving Lower In Monday's Pre-Market Session

BenzingaJun 17 07:41 ET

Moderna MRNA Candidate Chosen for FDA Rare Disease Therapy Acceleration Program

Seeking AlphaJun 6 10:13 ET

Larimar Therapeutics Insiders Placed Bullish Bets Worth US$540.7k

Simply Wall StJun 3 06:32 ET

Health Care Stocks Climb On Drug News -- Health Care Roundup

WSJMay 31 17:02 ET

Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session

BenzingaMay 31 13:17 ET

Larimar Therapeutics Shares Rise 15% Nomlabofusp Selected for FDA Program

WSJMay 31 10:43 ET

Ambarella Posts Upbeat Results, Joins Gap, PagerDuty, Elastic And Other Big Stocks Moving Higher On Friday

BenzingaMay 31 10:40 ET

Buy Rating Affirmed for Larimar Therapeutics as FDA Accelerates Nomlabofusp's Path in START Pilot Program

TipRanksMay 30 19:25 ET

Buy Rating on Larimar Therapeutics: Navigating FDA Approval With Promising FA Treatment

TipRanksMay 30 18:45 ET

Express News | Larimar Therapeutics Inc: Selected by FDA to Participate in Start Pilot Program for Nomlabofusp in Friedreich's Ataxia

ReutersMay 30 16:10 ET

Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich's Ataxia

GlobeNewswireMay 30 16:05 ET

Hello Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

BenzingaMay 28 05:45 ET

The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics

Yahoo FinanceMay 24 09:38 ET